Literature DB >> 6319565

Protein kinase activity in purified poliovirus particles and empty viral capsid preparations.

C E Schärli, G Koch.   

Abstract

Preparations of purified poliovirus type 1, strain Mahoney, and empty viral capsids contain a protein kinase activity. The gamma-phosphoryl group of [32P]ATP is transferred to all of the capsid proteins. Viral proteins phosphorylated in vitro are recognized by antiserum directed against isolated viral capsid proteins, indicating that phosphorylation does not alter the antigenic sites to such an extent that the recognition by antibodies is abolished. Viral capsid protein phosphorylation exposes new antigenic sites and leads to a destabilization of the virions. The transfer of 32P to viral proteins is linear for 90 min at 37 degrees C in the presence of 10 mM-Mg2+ at pH 8.1. Reducing agents or virus-stabilizing agents (such as arildone) reduce the kinase activity and result in a different pattern of capsid protein phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319565     DOI: 10.1099/0022-1317-65-1-129

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Properties of poliovirus associated protein kinase.

Authors:  M Lackmann; C Ueckermann; K Engelmann; G Koch
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  Detection of poliovirus antigen by enzyme immunoassay.

Authors:  P Ukkonen; A Huovilainen; T Hovi
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

3.  Poliovirus-associated protein kinase: destabilization of the virus capsid and stimulation of the phosphorylation reaction by Zn2+.

Authors:  M Ratka; M Lackmann; C Ueckermann; U Karlins; G Koch
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

4.  Proportions of immunoglobulin isotypes in paralytic poliomyelitis and after vaccination.

Authors:  I Julkunen; P Ukkonen; M Stenvik; T Hovi; L Renkonen; O Mäkelä
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.